Two studies focused on HMGB1, finding that spinal HMGB1 upregulation contributes to bone cancer pain and that treatment with anti-HMGB1 significantly reversed bone cancer-induced mechanical allodynia [38, 39]. This evidence concerns the gene HMGB1 and bone cancer.